http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111233809-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 |
| filingDate | 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111233809-B |
| titleOfInvention | Millepachine-CA-4 derivative and preparation method and application thereof |
| abstract | The invention discloses a Millepachine-CA-4 derivative, a preparation method and application thereof, the derivative has good stability, high anti-tumor activity and small toxic and side effects, effectively overcomes the defects that CA-4 has cardiovascular toxicity under high dosage, and CA-4 is unstable, is easy to photolyze, is easy to generate cis-trans isomerization, has poor water solubility and the like, and can be used for preparing anti-tumor medicaments. |
| priorityDate | 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.